Navigation Links
Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
Date:8/8/2008

1,031,007 1,251,649 1,754,114

NET LOSS $(11,002,390) $(4,801,707) $(20,956,387) $(8,159,011)

Basic and diluted

net loss per share $(0.14) $(0.07) $(0.27) $(0.11)

Shares used in

computing net

loss per share,

basic and

diluted 79,454,496 73,217,967 78,923,520 71,610,380

HALOZYME THERAPEUTICS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

AS OF JUNE 30, 2008 AND DECEMBER 31, 2007

June 30, December 31,

2008 2007

(unaudited)

ASSETS:

Cash and cash equivalents $82,410,139 $97,679,085

Accounts receivable 1,160,990 779,825

Inventory 649,254 703,468

Prepaid expenses and other assets 1,895,820 2,014,680

Total current assets 86,116,203 101,177,058

Property and equipment, net 2,439,765 2,283,316

Total Assets $88,555,968 $103,460,374

LIABILITIES AND STOCKHOLDERS' EQUITY:

Accounts payable $2,814,512 $3,055,637

Accrued expenses 3,338,896 2,502,259

Deferred revenue 3,255,461 3,306,225

Total current liabilities 9,408,869 8,864,121

Deferred revenue, net of current portion 38,376,170 35,963,266

Deferred rent, net of current portion 1,116,892 865,063

Stockholders' Equity:

Common stock 80,099 77,904

Additional paid-in capital 125
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Halozyme Therapeutics to Present at the Jefferies 2nd Annual Healthcare Conference
2. Halozyme Therapeutics Reports 2008 First Quarter Financial Results
3. Halozyme Therapeutics to Hold Pipeline Update Conference Call on May 9
4. Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results
5. Halozyme Therapeutics Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process at European Federation for Pharmaceutical Sciences
6. Halozyme Therapeutics to Hold Pipeline Update Conference Call on March 14
7. Halozyme Therapeutics to Present at the BIO CEO and Investor Conference and the Roth Growth Stock Conference
8. Halozyme Therapeutics Amends Stockholder Rights Plan
9. Halozyme Therapeutics Reports 2007 Third Quarter Financial Results
10. Halozyme Therapeutics to Present at UBS 2007 Global Life Sciences Conference
11. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Oct. 20, 2014 Mapp Biopharmaceutical,s valiant ... antibody therapeutic to fight the Ebola outbreak will ... time-consuming the production of pharmaceuticals can be, according ... said that while some may be taken aback ... those with industry knowledge are well aware of ...
(Date:10/20/2014)... /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today ... to $5.8 million and provides a good start to Q4.  The ... America and one in the Middle East ... record levels," said Peter Bruijns , President & CEO. "Total ... Q3 than they have been for any complete year since the ...
(Date:10/20/2014)... Oct. 20, 2014 PureTech , a ... big healthcare problems, announced today the closing of ... participation from Invesco Perpetual, a $120 Billion group ... drive PureTech,s existing pipeline forward and to advance ... the scientific creativity to really go for the ...
(Date:10/20/2014)... 20, 2014 Local veterinary surgeon, Dr. ... investigational study of donor stem cells for dogs with ... therapy and has performed clinical stem cell therapy for ... to determine if a single injection of donor stem ... help reduce pain and inflammation in the treated joints. ...
Breaking Biology Technology:Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2
... New Deal Advances the Company,s Groundbreaking Smart Shape Memory ... (BIO-SMP(TM)) Commercialization Program ... the pioneer,in the design, manufacture and commercialization of innovative,biocompatible ... global licensing agreement for an application of the,Company,s BIO-SMP(TM) ...
... MELBOURNE, Australia, Jan. 30 Phosphagenics,Limited ("Phosphagenics") (ASX: ... a pre-clinical study demonstrating that the,combination of its ... significantly reduced serum lipids and inflammatory proteins,involved in ... The purpose of the study was to determine ...
... composed of tightly packed nanostructures that resemble tiny nails, ... Laboratories have created a material that can repel almost ... the liquid on the surface slips past the heads ... wetting the surface completely. , The new material, which ...
Cached Biology Technology:mNEMOSCIENCE GmbH Announces Global Licensing Agreement With Aporo Biomedical 2mNEMOSCIENCE GmbH Announces Global Licensing Agreement With Aporo Biomedical 3Phosphagenics Reports Superior Pre-clinical Cholesterol Results from APA-01 and Atorvastatin Combination 2Phosphagenics Reports Superior Pre-clinical Cholesterol Results from APA-01 and Atorvastatin Combination 3Phosphagenics Reports Superior Pre-clinical Cholesterol Results from APA-01 and Atorvastatin Combination 4
(Date:10/18/2014)... for evaluation of suspected genetic conditions, whole-exome sequencing ... including detection of a number of rare genetic ... to a study appearing in JAMA . ... the American Society of Human Genetics annual meeting. ... regions of thousands of genes simultaneously using next-generation ...
(Date:10/17/2014)... for the first time how bacteria can grow directly ... the opportunity to get tremendous insights into bacteria behavior ... discovered the bacterial growth in chronic lung infections among ... by the immune cells. The researchers discovered the immune ... bacteria, forcing the bacteria to switch to a much ...
(Date:10/16/2014)... land managers have a new synthesis of recent research ... (MMC) forests in the two states. , The ... Oregon and Washington: A Synthesis of the Relevant Biophysical ... technical report published by the U.S. Forest Service,s Pacific ... request from managers for a synthesis of the large ...
Breaking Biology News(10 mins):Whole-exome sequencing shows potential as diagnostic tool 2Scientists opens black box on bacterial growth in cystic fibrosis lung infection 2New report synthesizes best available science on management of moist mixed-conifer forests 2
... Primate Research Center, Oregon Health & Science University, suggests ... counteract some negative impacts of smoking in unborn babies. ... mothers who continue to smoke throughout pregnancy despite physician ... of the American Journal of Respiratory and Critical Care ...
... National Human Genome Research Institute (NHGRI), part of the ... chromosomes have evolved by breaking at specific sites rather ... the breakage hotspots are also involved in human cancer. ... issue of the journal Science, a team of 25 ...
... that a protein prolonging life in mice works by controlling ... species. In mice, the researchers discovered, it acts as a ... Therapies based on this hormone could prove to be a ... Makoto Kuro-o, assistant professor of pathology and senior author of ...
Cached Biology News:OHSU research shows vitamin C counteracts some negative impacts of smoking on unborn babies 2OHSU research shows vitamin C counteracts some negative impacts of smoking on unborn babies 3Multi-species genome comparison sheds new light on evolutionary processes, cancer mutations 2Multi-species genome comparison sheds new light on evolutionary processes, cancer mutations 3Scientists find that protein controls aging by controlling insulin 2
... Sytem is a highly advanced digital ... digital imaging and automation technology that ... analysis, archving/retrieval and colored professional reporting. ... industry's fastest scanning and detection modules ...
... overlay agarose is used for second-dimension ... strips in place in PROTEAN Plus ... incorporated to allow monitoring of electrophoresis ... 0.75% agarose in 1x Tris, glycine, ...
... ReadyPrep overlay agarose, is a low ... sample setup to secure IPG strips in ... dye is incorporated to allow monitoring of ... 0.5% low melting point agarose in 1x ...
... super cooling coil, Trans-Blot cell, ... enzyme, high-intensity, and extended electrophoretic ... the Trans-Blot cell. Use of ... connection to an external water ...
Biology Products: